P S Goedegebuure - JoVE Visualize

Showing results (11-20 of 45) with videos related to

Pageof 5

Sort By:

Cancer Research|November 26, 1997

Clone 10d/BM28 (CDCL1), an early S-phase protein, is an important growth regulator of melanomaR A Spanjaard, P J Lee, S Sarkar, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1994

Human tumor-infiltrating CD4+ T cells react to B cell lines expressing heat shock protein 70I Yoshino, P S Goedegebuure, G E Peoples, et al.

International Immunology|January 1, 1990

Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysisP S Goedegebuure, E Braakman, D M Segal, et al.

International Journal of Cancer|December 18, 2001

Modification of the HER2/NEU-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytesY Tanaka, K D Amos, H G Joo, et al.

Annals of Surgical Oncology|November 1, 1996

Improved in vivo efficacy of tumor-infiltrating lymphocytes after restimulation with irradiated tumor cells in vitroU L Burger, M P Chang, M Nagoshi, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1995

Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancerD C Linehan, P S Goedegebuure, G E Peoples, et al.

Surgery|August 1, 1993

T-cell recognition of ovarian cancerG E Peoples, D D Schoof, J V Andrews, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1993

T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancerG E Peoples, M P Davey, P S Goedegebuure, et al.

Surgery|March 1, 1995

Recruitment of host CD8+ T cells by tumor-infiltrating lymphocytes and recombinant interleukin-2 during adoptive immunotherapy of cancerU L Burger, M P Chang, P S Goedegebuure, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1993

HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancerG E Peoples, P S Goedegebuure, J V Andrews, et al.

Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:

Pageof 5

Cancer Research|November 26, 1997

Clone 10d/BM28 (CDCL1), an early S-phase protein, is an important growth regulator of melanomaR A Spanjaard, P J Lee, S Sarkar, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1994

Human tumor-infiltrating CD4+ T cells react to B cell lines expressing heat shock protein 70I Yoshino, P S Goedegebuure, G E Peoples, et al.

International Immunology|January 1, 1990

Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysisP S Goedegebuure, E Braakman, D M Segal, et al.

International Journal of Cancer|December 18, 2001

Modification of the HER2/NEU-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytesY Tanaka, K D Amos, H G Joo, et al.

Annals of Surgical Oncology|November 1, 1996

Improved in vivo efficacy of tumor-infiltrating lymphocytes after restimulation with irradiated tumor cells in vitroU L Burger, M P Chang, M Nagoshi, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1995

Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancerD C Linehan, P S Goedegebuure, G E Peoples, et al.

Surgery|August 1, 1993

T-cell recognition of ovarian cancerG E Peoples, D D Schoof, J V Andrews, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1993

T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancerG E Peoples, M P Davey, P S Goedegebuure, et al.

Surgery|March 1, 1995

Recruitment of host CD8+ T cells by tumor-infiltrating lymphocytes and recombinant interleukin-2 during adoptive immunotherapy of cancerU L Burger, M P Chang, P S Goedegebuure, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1993

HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancerG E Peoples, P S Goedegebuure, J V Andrews, et al.

Pageof 5